CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.

Other languages Changjiang Pharmaceutical Group Co., Ltd.

Equities

300391

CNE100001XN8

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
4.16 ^CNY	+2.97%		+7.22%	-46.25%

Apr. 09	Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	MT
Apr. 01	Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	Apr. 09
Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	Mar. 31
YiChang HEC ChangJiang Pharmaceutical's Profit Surges in 2023	Mar. 28
Yichang Hec Changjiang Pharmaceutical Expects Up to 2,627% Profit Surge in 2023	Mar. 12
HEC ChangJiang Pharmaceutical Increases Transaction Limits Under 2 Contracts	Nov. 08
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24
HEC ChangJiang Pharmaceutical's Insulin Injection Cleared for Market Launch in China	23-09-26
HEC ChangJiang Pharmaceutical Returns to Profit on Surge in Anti-Viral Drug Sales	23-09-01
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22
China Greenlights New Drug Application for HEC ChangJiang Pharmaceutical's Hepatitis C Drug	23-08-16
HEC ChangJiang Pharmaceutical Forecasts Surge in H1 Profit; Shares Rise 5%	23-07-27
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd completed the acquisition of 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd.	23-07-24
HEC ChangJiang Pharma Repurchases $400 Million Convertible Bonds Issued to Blackstone	23-07-06
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27
Changjiang Pharma Units Sign 359 Million Yuan Contracts	23-04-17
YiChang HEC ChangJiang Pharma to Return to Profitability	23-03-20
YiChang HEC ChangJiang Pharmaceutical Shareholders to Vote on Disposal of 10% Stake in Controlling Shareholder	23-03-10
Kangyue Technology Adopts New Name After Shifting to Pharmaceuticals	23-03-02
Kangyue Technology to Change Company Name	23-02-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Changjiang Pharmaceutical Group Co., Ltd.

Equities

300391

CNE100001XN8

Other languages

Filters